FDA Approval Activities for this Drug…

Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S10 12/1/00 5/2/03 Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S12 7/25/01 5/2/03 Prograf (tacrolimus capsules ,tacrolimus injection) Fujisawa Healthcare NDA 50-708/S13 12/1/00 5/2/03 Prograf (tacrolimus capsules, tacrolimus injection) Fujisawa Healthcare NDA 50-708/S15,S16 Protopic (Tacrolimus) Ointment, 0.03%/0.1%, Fujisawa Healthcare NDA 50-777/S4 4/18/03 Protopic (Tacrolimus) Ointment, 0.03%/0.1%, Fujisawa Healthcare NDA 50-777 Protopic (Tacrolimus) Ointment, Fujisawa Healthcare Prograf (tacrolimus) Capsules, Fujisawa Healthcare Prograf (tacrolimus) Injection, Fujisawa Healthcare

For the latest approval information, please locate this drug using this index.